Please Wait.....
Report
Asia-Pacific ECMO Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality (Venoarterial ECMO, Venovenous ECMO, and Arteriovenous ECMO), Application (Respiratory and Cardiology), and Age Group (Adults, Pediatrics, and Neonates)
Market Report I 2023-01-20 I 129 Pages I The Insight Partners
The APAC ECMO market is expected to grow from US$ 110.85 million in 2022 to US$ 139.19 million by 2028. It is estimated to record a CAGR of 3.9% from 2022 to 2028.
Increasing Survival Rates with ECMO to Offer Opportunities for APAC ECMO Market During 2022-2028
The employment of ECMO for treating respiratory failure has been increasing in recent years, as treatments with ECMO show promising survival rates. Further, ECMO is recommended to treat patients suffering from acute respiratory distress syndrome (ADRS), primary graft dysfunction post lung transplant, and trauma to the lungs as it increases the survival rate of patients. Furthermore, ECMO increases the survival rate of patients affected by post-cardiac arrest regimen. A radical shift in adopting westernized lifestyles leads to various cardiac disorders. Thus, key players invest significantly in R&D, which results in improved treatment outcomes with ECMO with an increased survival rate. Therefore, the rising survival rate with ECMO use in various treatments is expected to provide lucrative opportunities for ECMO market in APAC during the forecast period.
APAC ECMO Market Overview
APAC is the fastest-growing regional ECMO market. China, India, and Japan are major contributors to the APAC ECMO market growth in the region. China dominated the market in 2022. According to an article by the National Center for Biotechnology Information (NCBI) titled "Cardiovascular Health and Diseases in China," Cardiovascular Disease (CVD) accounted for ~47% and 44% of all deaths in rural and urban areas, respectively, in 2019. Two out of every five deaths occur due to CVD, and it is predicted that over 330 million patients suffer from CVD in China. The patients suffering from stroke, heart failure, coronary heart disease, pulmonary heart disease, rheumatic heart disease, atrial fibrillation, lower extremity artery disease, congenital heart disease, and hypertension were found to be 13 million, 11 million, 9 million, 5 million, 4.87 million, 2.50 million, 2 million, 45.30 million, and 245.00 million, respectively. Moreover, according to Statista data, the population aged above 60 years is estimated to grow from 17.4% in 2020 to 30% by 2040. Thus, China is facing the pressures of an aging population and the constant rise in the prevalence of metabolic risk factors. As a result, the CVD burden will continue to increase, setting new requirements for CVD prevention, treatment, and the allocation of medical resources in China. Furthermore, the penetration of international market players in the country is boosting the growth of the ECMO market. In July 2021, Xenios AG, a Fresenius Medical Care company, received approval from the National Medical Products Administration (NMPA) in China for the Xenios console and patient kits for ECMO therapy. Hence, the rising prevalence of CVD, the increasing geriatric population, and advancements by key players are expected to propel the ECMO market in China during the forecast period.
APAC ECMO Market Revenue and Forecast to 2028 (US$ Million)
APAC ECMO Market Segmentation
The APAC ECMO market is segmented based on modality, application, age group, and country.
Based on modality, the APAC ECMO market is segmented into venoarterial ECMO, venovenous ECMO, and arteriovenous ECMO. The venoarterial ECMO segment held the largest market share in 2022.
Based on application, the APAC ECMO market is bifurcated into respiratory and cardiology. The respiratory segment held a larger market share in 2022.
Based on age group, the APAC ECMO market is segmented into adults, pediatrics, and neonates. The adults segment held the largest market share in 2022.
Based on country, the APAC ECMO market has been categorized into China, India, Japan, South Korea, Australia, and the Rest of APAC. Our regional analysis states that China dominated the market in 2022.
ABIOMED Inc, Braile Biomedica, Eurosets S.R.L., Fresenius Medical Care AG & Co KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corporation, Nipro Medical Corporation, and Terumo Group are the leading companies operating in the APAC ECMO market.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC ECMO Market - By Modality
1.3.2 APAC ECMO Market - By Application
1.3.3 APAC ECMO Market - By Age Group
1.3.4 APAC ECMO Market - By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC ECMO Market - Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5. APAC ECMO Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Cardiovascular Diseases and Respiratory Failures
5.1.2 Growing Adoption of ECMO in Lung Transplantation Procedures
5.2 Market Restraints
5.2.1 Complications Associated with ECMO
5.3 Market Opportunities
5.3.1 Increasing Survival Rates with ECMO
5.4 Future Trends
5.4.1 Surging Product Developments and Approvals
5.5 Impact Analysis
6. ECMO Market - APAC Analysis
6.1 APAC ECMO Market Revenue Forecast & Analysis
7. APAC ECMO Market Analysis - By Modality
7.1 Overview
7.2 APAC ECMO Market Share by Modality 2021 & 2028 (%)
7.3 Venoarterial ECMO
7.3.1 Overview
7.3.2 Venoarterial ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)
7.4 Venovenous ECMO
7.4.1 Overview
7.4.2 Venovenous ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)
7.5 Arteriovenous ECMO
7.5.1 Overview
7.5.2 Arteriovenous ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)
8. APAC ECMO Market Analysis - By Application
8.1 Overview
8.2 APAC ECMO Market, By Application 2021 & 2028 (%)
8.4 Respiratory
8.4.1 Overview
8.4.2 Respiratory Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Cardiology
8.5.1 Overview
8.5.2 Cardiology Market Revenue and Forecast to 2028 (US$ Mn)
9. APAC ECMO Market Analysis - By Age Group
9.1 Overview
9.2 APAC ECMO Market, By Age Group 2021 & 2028 (%)
9.3 Adults
9.3.1 Overview
9.3.2 Adults Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Pediatrics
9.4.1 Overview
9.4.2 Pediatrics Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Neonates
9.5.1 Overview
9.5.2 Neonates Market Revenue and Forecast to 2028 (US$ Mn)
10. APAC ECMO Market - Country Analysis
10.1 Overview
10.1.1 APAC: ECMO Market, by Country, 2021 & 2028 (%)
10.1.1.1 China: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 China: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 China: ECMO Market, by Modality, 2020-2028 (US$ Million)
10.1.1.1.4 China: ECMO Market, by Application, 2020-2028 (US$ Million)
10.1.1.1.5 China: ECMO Market, by Age Group, 2020-2028 (US$ Million)
10.1.1.2 Japan: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Japan: ECMO Market, by Modality, 2020-2028 (US$ Million)
10.1.1.2.4 Japan: ECMO Market, by Application, 2020-2028 (US$ Million)
10.1.1.2.5 Japan: ECMO Market, by Age Group, 2020-2028 (US$ Million)
10.1.1.3 India: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 India: ECMO Market, by Modality, 2020-2028 (US$ Million)
10.1.1.3.4 India: ECMO Market, by Application, 2020-2028 (US$ Million)
10.1.1.3.5 India: ECMO Market, by Age Group, 2020-2028 (US$ Million)
10.1.1.4 South Korea: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 South Korea: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 South Korea: ECMO Market, by Modality, 2020-2028 (US$ Million)
10.1.1.4.4 South Korea: ECMO Market, by Application, 2020-2028 (US$ Million)
10.1.1.4.5 South Korea: ECMO Market, by Age Group, 2020-2028 (US$ Million)
10.1.1.5 Australia: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Australia: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Australia: ECMO Market, by Modality, 2020-2028 (US$ Million)
10.1.1.5.4 Australia: ECMO Market, by Application, 2020-2028 (US$ Million)
10.1.1.5.5 Australia: ECMO Market, by Age Group, 2020-2028 (US$ Million)
10.1.1.6 Rest of APAC: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of APAC: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of APAC: ECMO Market, by Modality, 2020-2028 (US$ Million)
10.1.1.6.4 Rest of APAC: ECMO Market, by Application, 2020-2028 (US$ Million)
10.1.1.6.5 Rest of APAC: ECMO Market, by Age Group, 2020-2028 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Terumo Group
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 MicroPort Scientific Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 LivaNova Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Nipro Medical Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Eurosets S.R.L.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Getinge AB
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Braile Biomedica
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Fresenius Medical Care AG & Co KGaA
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 ABIOMED Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. APAC ECMO Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. China ECMO Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 3. China ECMO Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 4. China ECMO Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
Table 5. Japan ECMO Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 6. Japan ECMO Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 7. Japan ECMO Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
Table 8. India ECMO Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 9. India ECMO Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 10. India ECMO Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
Table 11. South Korea ECMO Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 12. South Korea ECMO Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 13. South Korea ECMO Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
Table 14. Australia ECMO Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 15. Australia ECMO Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 16. Australia ECMO Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of APAC ECMO Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of APAC ECMO Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of APAC ECMO Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
Table 20. Recent Inorganic Growth Strategies
Table 21. Recent Organic Growth Strategies
Table 22. Glossary of Terms
LIST OF FIGURES
Figure 1. APAC ECMO Market Segmentation
Figure 2. APAC ECMO Market, By Country
Figure 3. APAC ECMO Market Overview
Figure 4. APAC ECMO Market, By Modality
Figure 5. APAC ECMO Market, By Country
Figure 7. APAC: PEST Analysis
Figure 8. Experts Opinion
Figure 9. Impact Analysis: APAC ECMO Market
Figure 10. APAC ECMO Market - Revenue Forecast and Analysis
Figure 11. APAC ECMO Market Share by Modality 2021 & 2028 (%)
Figure 12. Venoarterial ECMO: APAC ECMO Market Revenue and Forecast To 2028 (US$ Million)
Figure 13. Venovenous ECMO: APAC ECMO Market Revenue and Forecast To 2028 (US$ Million)
Figure 14. Arteriovenous ECMO: APAC ECMO Market Revenue and Forecast To 2028 (US$ Million)
Figure 15. APAC ECMO Market, by Application 2021 & 2028 (%)
Figure 16. Respiratory : APAC ECMO Market Revenue and Forecasts To 2028 (US$ MN)
Figure 17. Cardiology : APAC ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. APAC ECMO Market, by Age Group 2021 & 2028 (%)
Figure 19. Adults : APAC ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Pediatrics : APAC ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. Neonates : APAC ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. APAC: ECMO Market, by Key Country - Revenue (2021) (US$ Million)
Figure 23. APAC: ECMO Market, by Country, 2021 & 2028 (%)
Figure 24. China: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Japan: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. India: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. South Korea: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Australia: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Rest of APAC: ECMO Market - Revenue and Forecast to 2028 (US$ Million)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security